Drawing for PROPEL HEALTH

USPTO serial 97262818

PROPEL HEALTH

Reviewed by CopyMark Law Group

Reg. 8439194Status 700Registered
Filing date
Status date
Registration date
Sep 15, 2026
Examiner
GULIANO, ROBERT N
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PROPEL HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsey N. Rothrock

Lindsey N. Rothrock TAFT STETTINIUS & HOLLISTER LLPONE INDIANA SQUARESUITE 3500INDIANAPOLIS, IN 46204

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services featuring planning, creating, developing, facilitating and coordinating strategies for professional, healthcare professional, patient, and speaker engagements; Business consultancy and marketing consultancy, both featuring strategic planning, coordination, development, implementation and execution of medical communications and healthcare communications; Business consultancy and marketing consultancy in the field of developing printed, digital and visual medical and scientific materials and content, developing and managing opinion leader identification, and developing, implementing and supporting programs, events, meetings, presentations and engagements, all of the foregoing for business purposes in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Business consulting and marketing consulting services in the fields of healthcare patient engagements, patient ambassador engagements and caregiver engagements; Business consultancy and marketing consultancy in the field of creating and modifying content for, developing, planning and coordinating for others live and virtual activities, engagements, programs, events, presentations and meetings for business purposes; Business consulting and marketing consulting services in the fields of event planning and event venue planning for business purposes; Business management of logistics for others for live and virtual activities, engagements, programs, events, presentations and meetings; Providing business support, business administration and business management assistance in the execution, coordination and management of live and virtual activities, engagements, programs, events, presentations and meetings for business purposesACTIVEDec 31, 2022
041Educational services, namely, developing educational programs, events, meetings, presentations and engagements, all in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Consulting about education including assisting in the selection and training of speaker bureaus, and assisting in the convening of advisory boards, all in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Consulting about education in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Developing, planning, and coordinating for others live and virtual educational activities, engagements, programs, events, presentations and meetings in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Developing, planning, and coordinating for others live and virtual educational activities, engagements, programs, events, presentations and meetings for healthcare patients, patient ambassadors, and caregivers, all of the foregoing in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Consulting about education in the fields of healthcare patient education, patient ambassador education and caregiver education; Consulting about education in the fields of event planning and event venue planning for educational purposes; Providing assistance in the nature of training services in the field of execution, coordination and management of live and virtual activities, engagements, programs, events, presentations and meetings for educational purposes; Video production services in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated productsACTIVEDec 31, 2022
042Developing, implementing, and hosting computer software platforms and mobile applications for use in conducting needs assessments for, planning, recruiting for, registering for, facilitating, managing, and ensuring compliance of live and virtual activities, engagements, programs, events, presentations and meetings for business and educational purposes, and providing computer software technical support services for and IT consulting services relating to the installation, maintenance and repair of the aforementioned computer software; Developing, implementing, and hosting computer software platforms and mobile applications for use in speaker bureau management, and providing computer software technical support services for and IT consulting services relating to the installation, maintenance and repair of the aforementioned computer software; Software as a service (SaaS) services featuring software for use in assessing, planning, recruiting for, registering for, facilitating, managing, and ensuring compliance of professional, healthcare professional, patient, and speaker engagements in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Software as a service (SaaS) services featuring software for use in conducting needs assessments for, planning, recruiting for, registering for, facilitating, managing, and ensuring compliance of live and virtual activities, engagements, programs, events, presentations and meetings for business and educational purposes; Software as a service (SaaS) services featuring software for use in conducting needs assessments for, planning, recruiting for, registering for, facilitating, managing, and ensuring compliance of live and virtual consulting, advisory board, training, promotional, educational, speaker-led and medical research activities, engagements, programs, events, presentations and meetings in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Software as a service (SaaS) services featuring software for use in speaker bureau management; Providing medical communication and healthcare communication services, namely, technical writing in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Software as a service (SaaS) services featuring software for use in creating, distributing, publishing, planning, facilitating, coordinating, managing and ensuring compliance of medical communications and healthcare communications; Software as a service (SaaS) services featuring software for use in conducting needs assessments for, planning, recruiting for, registering for, facilitating, managing, and ensuring compliance of live and virtual healthcare patient, patient ambassador and caregiver activities, engagements, programs, events, presentations and meetings in the fields of healthcare, pharmaceuticals, life sciences, medical devices and other regulated products; Software as a service (SaaS) services featuring software for use in selecting, contracting with, supporting and managing patient ambassadors and caregivers within the healthcare industry; all of the foregoing excluding services consisting of or related to computer software for the diagnosis of medical conditions, and all of the foregoing excluding services consisting of or related to computer software for the management and processing of patient health dataACTIVEDec 31, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Sep 15, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 15, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 14, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 14, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 11, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 23, 2026IUAFUSE AMENDMENT FILED—
Jun 23, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 24, 2025EX3GSOU EXTENSION 3 GRANTED—
Dec 24, 2025EXT3SOU EXTENSION 3 FILED—
Dec 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 30, 2025EX2GSOU EXTENSION 2 GRANTED—
Jun 30, 2025EXT2SOU EXTENSION 2 FILED—
Jun 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2024EX1GSOU EXTENSION 1 GRANTED—
Dec 21, 2024EXT1SOU EXTENSION 1 FILED—
Dec 21, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 20, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 17, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 17, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 17, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 19, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 20, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 20, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 20, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 25, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 25, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2022DOCKASSIGNED TO EXAMINER—
Aug 17, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 16, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance